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Abstract
Background: Breast spindle cell tumours (BSCTs), although rare, represent a heterogeneous
group with different treatment modalities. This work was undertaken to evaluate the utility of fine
needle aspiration cytology (FNAC), histopathology and immunohistochemistry (IHC) in
differentiating BSCTs.
Methods: FNAC of eight breast masses diagnosed cytologically as BSCTs was followed by wide
excision biopsy. IHC using a panel of antibodies against vimentin, pan-cytokeratin, s100, desmin,
smooth muscle actin, CD34, and CD10 was evaluated to define their nature.
Results: FNAC defined the tumors as benign (n = 4), suspicious (n = 2) and malignant (n = 3),
based on the cytopathological criteria of malignancy. Following wide excision biopsy, the tumors
were reclassified into benign (n = 5) and malignant (n = 3). In the benign group, the diagnosis was
raised histologically and confirmed by IHC for 3 cases (one spindle cell lipoma, one
myofibroblastoma and one leiomyoma). For the remaining two cases, the diagnosis was set up after
IHC (one fibromatosis and one spindle cell variant of adenomyoepithelioma). In the malignant
group, a leiomyosarcoma was diagnosed histologically, while IHC was crucial to set up the diagnosis
of one case of spindle cell carcinoma and one malignant myoepithelioma.
Conclusion: FNAC in BSCTs is an insufficient tool and should be followed by wide excision
biopsy. The latter technique differentiate benign from malignant BSCTs and is able in 50% of the
cases to set up the definite diagnosis. IHC is of value to define the nature of different benign lesions
and is mandatory in the malignant ones for optimal treatment. Awareness of the different types of
BSCTs prevents unnecessary extensive therapeutic regimes.
Background
BSCTs although rare, include benign and malignant
lesions, necessitating different therapeutic approaches.
Within the benign group that may mimics carcinoma clin-
ically and radiologically, and are treated by conservative
approach, one should differentiate between spindle cell
lipoma (SCL) [1,2] myofiboblastoma (MFB) [3], fibroma-
tosis [4,5], myoepithelioma (ME) [6,7], leiomyoma [8,9],
solitary fibrous tumor (SFT) [10], nodular fasciitis [4,11],
and benign nerve sheath tumor [12,13]. Noteworthy,
although benign in nature, some these tumors such as
fibromatosis and SFT have tendency for local recurrence
[4,5,11]; therefore the distinction between them is of
prognostic significance. In the malignant BSCTs, should
be identified, malignant phyllode tumor (PT) [14,15], lei-
omyosarcoma [16,17] malignant myoepithelioma
(MME) [6,7], malignant peripheral nerve sheath tumor
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[18], spindle cell carcinoma (SCC) [19,20] and metastatic
spread from sarcomas.
This study emphasizes the combined role of FNAC and
histopathology and the importance of IHC in BSCTs as
the treatment modalities are different and crucial for
patients' care.
Materials and methods
Patients and tissues
The study involved eight female cases complaining of
breast masses and referred from surgeons for FNAC. Clin-
ically, all lesions were highly suggestive of malignancy.
The initial cytological diagnosis was that of BSCTs. Malig-
nancy was ruled out in four cases due to [1] lack of cyto-
logic atypia, [2] absence of necrosis, and [3] paucity of
mitotic figures. Wide excision biopsy enabled to differen-
tiate between benign and malignant BSCTs but was insuf-
ficient to reach a final definite diagnosis. Therefore, the
precise nomination and the cell of origin or the nature of
the lesions was based on IHC.
Immunohistochemistry
IHC was effectuated on 5 μm thick paraffin embedded tis-
sue sections. The antibodies in the study, their sources,
clones, the heat induced epitope antigen retrieval (HIER)
and dilutions are illustrated in table 1. HIER was done by
heating the slides in microwave (800 watts) for 15 min-
utes (3 cycles × 5 minutes).
In brief, slides were hydrated in descending grades of alco-
hol followed by distilled water. Endogenous peroxidase
activity was quenched by 0.3% hydrogen peroxide for 5
minutes followed by rinsing in distilled water and three
times wash in phosphate buffer saline (PBS) Ph 7.4. The
antibodies were incubated for 30 minutes at room tem-
perature, and then the slides were rinsed in successive
bathes of PBS. The revelation was done by the LSAB-2
detection kit (Dakocytomation) according to the manu-
facturer's instructions. Finally, diaminobenzidine tetra-
chloride (DAB) was applied for 5 minutes. Slides were
counterstained in Harris haematoxylin (Hx), dehydrated,
cleared in xyelene and coverslipped.
The control tissue for all antibodies was the normal breast
tissue. In addition, blood vessels inside the tumors were
used as an internal control tissue for all the antibodies
except cytokeratin. Ommittment of the antibodies were
used as negative control for the procedure. The staining
interpretation is summarized in table 1.
IHC results were evaluated in semi-quantitative manner
as following: 0, negative staining with positive control, -/
+ when rare cells not exceeding 10% of the total popula-
tion are positive, +/- when positivity is between 10 % and
50%, and + when more than 50% of the cells are positive.
Results
The age group for the BSCTs ranged from 37–69 years
with a median age of 50.37 years. The common denomi-
nator on FNAC was the presence of spindle cells without
ductal epithelial cells. Lesions diagnosed as benign BSCTs
were formed by variable mixtures of spindle, oval and
ovoid cells with bland nuclei, inconspicuous nucleoli and
low mitotic rate (fig 1a). The presence of discohesive cells
with mitotic activity, nuclear atypia and abnormal mitosis
in a necrotic background favoured the diagnosis of malig-
nant tumours (Fig 4a, b). In two controversial cases, sus-
picion of malignancy was raised. The reports were signed
out as begnin, suspicious or malignant BSCTs. Cytological
evaluation was followed by wide excision biopsy. Grossly,
all the lesions were well circumscribed except two. Histo-
logically, the main finding of all the lesions was the pres-
ence of spindle cells. Here also, the bland cellular
morphology of the spindle cells, mitotic activity not
exceeding 2 mitosis/10 high power fields (hpfs) and
absence of necrosis, qualify the lesions as benign. Other-
wise, the lesion was diagnosed as malignant. Depending
on the different proportions of other cellular component,
a proposed diagnosis or a differential diagnosis was
Table 1: The antibodies used in the study
Antibodies Source Antibody HIER Dilution Staining interpretation
Vimentin DakoCytomation Mo V9 2 1:50 Cytoplasmic
Cytokeratin DakoCytomation Mo AE1/AE3 1 1: 50 Cytoplasmic
S100 DakoCytomation Rabbit polyclonal 1 1: 500 Cytoplasmic +/-
nuclear
Desmin DakoCytomation Mo D33 2 prediluted Cytoplasmic
SMA DakoCytomation Mo 1A4 2 1:50 Cytopmasmic
CD34 Biogenex Mo QBEnd 10 2 Prediluted Membranous
CD10 Novocastra NCL-CD10-270 1 1:50 Membranous
Mo: mouse monoclonal.
1-Tris-EDTA pH9.0.
2-Citrate buffer pH6.0.Diagnostic Pathology 2006, 1:13 http://www.diagnosticpathology.org/content/1/1/13
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based. Table 2 summarizes the patients' pathological data
and table 3 the IHC profile of the diagnosed cases. Figures
1 through 5 illustrate the cytological, histopathological
and IHC findings of some cases.
Discussion
The diagnosis of the first case (fig 1), SCL was raised on
histopathological basis and confirmed after IHC. Histo-
logically, the lesion consisted essentially of spindle cells
intermingled with adipocytes and collagen bundles, fea-
tures described for soft tissue and breast SCL [1,2,21].
However, contrary to the infiltrative nature of the lesion
described by Mulvany et al [2], no mammary tissue was
seen entrapped in SCL in the present work. In addition,
mast cells usually identified in SCL of soft tissue [21] were
not found here. IHC confirmed the histological diagnosis
and showed reactivity of the spindle cells for vimentin
and CD34, finding previously described [2,21].
MFB is a tumor closely related to SCL [22,23] (case 2, fig
2). However, contrary to the begnin cytological nature of
SCL, MFB was unobvious based on the presence of nuclear
pleomorphism in some spindle cells. This finding is con-
sistent with other studies, cytologically misinterpreting
this tumor as malignant soft tissue tumor or PT [24,25].
Histologically, MFB was formed of spindle cells, hyali-
nized collagen bundles and adipocytes, criteria previously
described by in the original study by Wargotz and col-
leagues[3]. The diagnosis of this case was based on IHC
positivity for vimentin, CD34, desmin and focal positivity
for SMA, a finding described in the literature [26]. While
all the literature agrees on the positivity of MFB for vimen-
tin and CD34, controversies regarding the positivity for
desmin and SMA are reported [3,27].
This tumor, of myofibroblastic origin, is capable of
diverse lines of differentiation [28]; and based on the pro-
portion of the spindle cells, collagenous stroma and cellu-
lar pleomorphism, is subclassified as classic, collagenized,
epithelioid, cellular, lipomatous and variants resembling
SFT [22,27,29]. Therefore this case was signed out as col-
lagenized MFB. It is crucial to recognize this tumor and to
distinguish it from its malignant counterpart, myofibrosa-
rcoma. The latter, characterized by marked cellular pleo-
morphism, infiltrating margins and high mitotic rate,
necessitate more aggressive extensive and radical surgery
[30].
At a molecular level, MFB shares cytogenetic abnormali-
ties with SCL [23], leading to the hypothesis of a dual,
myofibroblastic and lipomatous, differentiation from a
common pluripotential mesenchymal precursor cell, rep-
resented by the vimentin+/CD34+ fibroblast of the mam-
mary stroma as suggested by Magro and co-workers [28].
In latter studies, the same investigators postulated that the
"vimentin+/CD34+ cell" is the precursor cell of all benign
spindle cell neoplasm [31,32]. This hypothesis provides
explanation for the phenotypic heterogeneity of these
neoplasm and their variable IHC profiles taking into con-
sideration the well-known inherent plasticity of the
myofibroblastoma Figure 2
myofibroblastoma. (a) Most of the tumor is formed of 
hyalinized collagen bundles surrounded by spindle cells, H&E 
× 400. (b) Cellular area formed of palissading spindle cells, 
H&E × 400. (c) Staining of spindle and oval cells is more pro-
nounced in the lower right part, CD34 IHC, DAB, Hx × 400. 
(d) Focal area of spindle and oval cells positive for SMA, IHC, 
DAB, Hx ×400. See additional files 5, 6, 7, 8 for higher reso-
lution images.
spindle cell lipoma Figure 1
spindle cell lipoma. (a) Benign cytology BSCT, moderately 
cellular smear with benign looking spindle cells, Papanicolaou 
× 400. (b) Bland spindle cells intermingled with mature adi-
pocytes and thick collagen bundles, H&E × 400. (c) Another 
field of the same case where the adipocytes are less promi-
nent compared to "b", H&E × 400. (d) Adipocytes and spin-
dle cells positive for CD34 IHC, DAB, Hx, × 400. See 
additional files 1, 2, 3, 4 for higher resolution images.Diagnostic Pathology 2006, 1:13 http://www.diagnosticpathology.org/content/1/1/13
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"vimentin+/CD34+ cell" to differentiate toward several
mesenchymal lines.
Breast fibromatosis (case 3) is a lesion that clinically and
radiologically suggests breast cancer [33,34]. Fibromatosis
is an infiltrative fibroblastic and myofibroblastic prolifer-
ation with significant risk for local recurrence, without
metastatic potential. Specific histological features, such as
size, cellularity, atypia, and mitotic figures, are not helpful
in predicting recurrence [5]. The diagnosis of fibromatosis
in this work was based on positivity of the spindle cells for
vimentin and SMA, a finding described in other studies
[35,36].
ME tumors are defined as lesions arising from or com-
posed of a dominant to pure population of myoepithelial
cells (ME cells) in the WHO classification 2003 [7]. ME
cells are immunoreactive for SMA, CD10, s100, CK and
high molecular weight CK [7,37,38]. ME tumors are
divided into myoepitheliosis, adenomyoepithelial adeno-
sis, ME and MME. A case of spindle cell ME (case 4) has
been diagnosed by IHC. Cells were strongly reactive for
CK, s100, SMA and focally positive for CD10. Variable lev-
els of expression for CD10 have been reported depending
on the type of ME tumors [39]. It has been postulated that
CD10 expression in combination with SMA is more
informative on ME cells' nature [40]. A second tumor
encountered here of ME origin is MEC (case 5, fig 3). His-
tologically, it mimicked malignant PT, as it was composed
of malignant spindle cells surrounding luminal epithelia.
However, based on the negativity of the spindle cells for
CD34 and their positivity for CK, s100, SMA and CD10
[37,38], the diagnosis of malignant PT have been
excluded. This diagnosis is important in view of the
aggressive behaviour of MME compared to malignant PT
[41,42].
Table 3: IHC profile of the studied cases
Provisional diagnosis Vimentin CK S100 Desmin SMA CD34 CD10 Final diagnosis
1S C L ? + - - - - + - S C L
2 MFB? + - - + +/- + - MFB
3 Benign BSCTs? + - - - + - Fibromatosis
4 Benign BSCTs? - + + - +/- - -/+ ME
5 Malignant PT? - + + - -/+ +/- MME
6 leiomyoma + - - + + - - Leiomyoma
7 leiomyosarcoma + - - + + - - Leiomyosarcoma
8 Malignant BSCTs? -/+ + + - + - + SCC
- negative.
-/+ rare cells not exceeding 10% of the total population.
+/-between 10 and 50%.
+ more than 50%.
Table 2: Patients' pathological summaries
N° Age Cytology Gross pathology Histopathology Provisional 
diagnosis
1 54 Benign Well defined, 2 cm Spindle cells, adipocytes, thick collagen bundles in variable 
proportions
SCL?
2 55 Suspicious Well defined, 3 cm Spindle and oval cells haphazardly arranged in short 
intersecting fascicles, ribbons of collagen
MFB?
3 46 Benign Irregular infiltrative, 3.7 cm Spindle cells forming interlacing bundles Benign BSCTs?
4 37 Benign Well defined, 2.5 cm Cellular neoplasm formed of spindle and oval cells, 
arranged in storiform pattern or in parallel fascicles
Benign BSCTs?
5 51 Suspicious Well defined with irregular margins, 3 cm Highly cellular neoplasm formed of spindle cells 
surrounding epithelial lined spaces, high mitotic activity 20/
10 hpfs
Malignant PT?
6 39 Benign Well defined, 4 cm Interlacing bundles of spindle-shaped cells with cigar 
shaped-nuclei, eosinophilic cytoplasm, rare mitotic figures
leiomyoma
7 52 Malignant Well defined, 5 cm Eosinophilic spindle cells arranged in interlacing bundles, 
marked cellular and nuclear atypia, mitosis 7/10 hpfs, wide 
areas of necrosis
leiomyosarcoma
8 69 Malignant Well defined, 4 cm Highly pleomorphic spindle cells, high mitotic activity 23/
10hpfs
Malignant BSCTs?
Hpfs: high power fields.Diagnostic Pathology 2006, 1:13 http://www.diagnosticpathology.org/content/1/1/13
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Two smooth muscle tumors had been encountered in this
study, leiomyoma and leiomyosarcoma. These tumors,
since their initial description by Strong [8], are rare breast
neoplasm. Two types of breast leiomyoma are identified,
superficial and vascular leiomyoma. Superficial leiomyo-
mas, are located in the skin and subcutaneous tissues and
involve the nipple or areolar region, while vascular leio-
myomas are located deep within the breast parenchyma
and are less common than the superficial counterpart. The
true histogenesis of breast smooth muscle tumors remains
unknown. Cells may be considered as hamartomatous
proliferation of smooth muscle surrounding blood ves-
sels, embryonal migration of smooth-muscle cells from
the nipple, differentiation from multipotent mesenchy-
mal cells in breast tissue or derivation from myoepithelial
cells of breast ducts with frank differentiation to smooth
muscle [9,43]. The leiomyoma diagnosed in the present
work (case 6) was a deep one arising from smooth mus-
cles around blood vessels. Histologically, it demonstrated
interlacing bundles of spindle cells with blunt-ended cigar
shaped nuclei, and eosinophilic cytoplasm. There was no
nuclear atypia, no hypercellularity. The mitotic rate was
low and necrosis was absent. However, the importance
resides in differentiating leiomyoma from leiomyosar-
coma. The latter diagnosis has been made for case 7 (fig
4). On cytological basis, it was difficult to nominate the
lesion which was designed as malignant BSCT. The same
difficulty has been reported in other studies, as the tumor
was misdiagnosed as poorly differentiated ductal carci-
noma or as malignant PT [16,17]. By the contrary, histo-
logically, it fulfilled the criteria for diagnosing
leiomyosarcoma. In addition, cells were centred on blood
vessels, a feature identified for the leiomyoma case. On
IHC bases, both leiomyoma and leiomyosarcoma were
positive for both SMA and desmin (fig 5).
SCC of the breast, account for less than 1% of invasive car-
cinoma [44]. It represents a variant of metaplastic carci-
noma (MSC), and includes a wide spectrum of lesions
with histomorphologic and nuclear features ranging from
overtly malignant to mildly atypical. The case presented in
this study (case 8, fig 5) was suspicious for malignancy on
FNAC, based on the presence of some atypical nuclei in
the spindle cells and scattered mitotic activity. This corre-
sponded histologically to bland areas with mildly pleo-
morphic cells and low mitotic activity, while most of the
tumor was formed of frankly malignant cells with a
mitotic activity up to 23 mitosis/10 hpfs. Vimentin, CK,
SMA s100 and CD10 were positive on the spindle cells
while desmin and CD34 were negative. The expression of
SMA, s100 and CD10 on SCC favour the current concept
of its myoepithelial origin [15,19,45,46]. Controversies in
the literature exist concerning the prognosis being better
or worse compared to ordinary breast duct carcinoma
[19,20,47-49].
Conclusion
In conclusion, although BSCTs are infrequent, awareness
of this category is essential for patient categorization and
optimal therapy. The combination of conventional H&E
and IHC using a small panel of antibodies is fundamental.
The role of cytology is less obvious in this category.
myoepithelial carcinoma Figure 3
myoepithelial carcinoma. (a) Spindle cell proliferation 
surrounding epithelial lumina, H&E × 400. (b) Higher power 
view showing pleomorphic spindle cells with eosinoplilic and 
clear cytoplasm surrounding an epithelial lined space, H&E × 
400. (c) Another area showing pleomorphic spindle and 
ovoid cells with eosinophilic cytoplasm arranged in fascicles; 
cells have high mitotic activity, H&E × 400. (d) Pleomorphic 
spindle and ovoid cells with clear cytoplasm arranged in wavy 
fascicles, H&E × 400. (e) s100 p IHC staining of the myoepi-
thelial cells around the epithelial lumina and the neoplastic 
spindle cells × DAB, Hx, ×10. (f) Higher magnification of "fig 
4e" showing staining of almost all the cells for s100 p IHC, 
DAB, Hx, × 400. (g) CD10 IHC, DAB, Hx, × 400. see addi-
tional files 9, 10, 11, 1213, 14, 15 for higher resolution 
images.Diagnostic Pathology 2006, 1:13 http://www.diagnosticpathology.org/content/1/1/13
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spindle cell carcinoma Figure 5
spindle cell carcinoma. (a) Area with bland morphology 
compared to "fig 4b", H&E ×400. (b) Area with pleomorphic 
cells, and high mitotic activity, H&E × 400. (c) CK IHC, DAB, 
Hx, × 400. (d) CD10 IHC, DAB, Hx, × 400. (e) s100p, DAB, 
Hx, × 400 f- SMA IHC, DAB, Hx, × 400. See additional files 
23, 24, 25, 2627, 28 for higher resolution images.
leiomyosarcoma Figure 4
leiomyosarcoma. (a) Malignant BSCTs cytology, cellular 
smear with sheets of spindle cells, Papanicolaou staining × 
400. (b) Another field showing neoplastic ovoid cells, Papan-
icolaou staining × 400. (c) Well circumscribed tumor pushing 
the normal ductal cells at the periphery, H&E × 10. (d) Spin-
dle cells are merging from blood vessels, H&E, × 10. (e) 
Desmin IHC highlighting cells merging from the blood ves-
sels, DAB Hx × 400. (f) Intersecting fascicles of pleomorphic 
malignant spindle cells having cigar shaped blunt ended nuclei, 
H&E, × 400. (g) Desmin IHC, DAB, Hx × 400. See additional 
files 16, 17, 18, 1920, 21, 22 for higher resolution images.Diagnostic Pathology 2006, 1:13 http://www.diagnosticpathology.org/content/1/1/13
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